Category: Healthcare and Pharmaceutical
Publish Date: August 2023
No. of Pages: 200
Format: Pdf
Licensing options
Executive Summary
Azoth Analytics has released a research report titled “High Potency API Contract Manufacturing Market (2023 Edition)†which provides a complete analysis of the global High Potency API Contract Manufacturing industry in terms of market segmentation by Formulation (Injectables, Oral Solids, Lotions, Other Formulations) and by End Use (Oncology, Antidiabetics, Autoimmune, Others) at the global, regional and country-level for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, Switzerland, Belgium, Spain, China, India, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
The Global High Potency API Contract Manufacturing Market is expected to generate USD 21.12 billion by the end of 2029, up from USD 10.89 Billion in 2022. During the forecast period, 2024-2029, the Global High Potency API Contract Manufacturing market is expected to grow at a CAGR of 10.2%.
HPAPI contract manufacturing is a dynamic sector of the pharmaceutical industry specialising in the production of potent and complex therapeutic compounds. HPAPIs are distinguished by their substantial potency and low therapeutic quantities, often demanding careful handling as well as manufacturing procedures to guarantee both their safety and effectiveness.
Rising healthcare expenditures, particularly in developing nations, have been a key factor in the expansion of the contract manufacturing sector due to rising HPAPI demand among the local pharmaceutical companies looking to expand their product portfolio. Governments and the private sector are making investments in R&D and improving access to advanced therapies.
Additionally, a growing number of mid-scale pharmaceutical companies are also backing the market growth, as contract manufacturing enables them to produce such high-potency drugs without making large capital investments.
Scope of the Report:
• The report analyses the High Potency API Contract Manufacturing Market by Value (USD Billion).
• The report presents the analysis of the High Potency API Contract Manufacturing Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the High Potency API Contract Manufacturing Market by Formulation (Injectables, Oral Solids, Lotions Other Formulations).
• The report analyses the High Potency API Contract Manufacturing Market by End Use (Oncology, Antidiabetics, Autoimmune, Other End Uses).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Lonza, Catalent, Inc., Piramal Pharma Solutions, Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie Contract Manufacturing, Corden Pharma International, Curia Global, Inc., Merck Group (SigmaAldrich Co., LLC) and Polpharma Group.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Geographical expansion
2.2 Environmentally Sustainable Contract Manufacturing of HPAPI
3. Global HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)
3.1 Age-standardised cancer incidence rate, 2020
3.2 Prevalence of Cancer
3.3 Competitive Landscape for Highly Potent Oncology Drugs in Pipeline
3.4 Global HPAPI Contract Manufacturing Market: Dashboard
3.5 Global HPAPI Contract Manufacturing Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on Global HPAPI Contract Manufacturing Market
3.7 Global HPAPI Contract Manufacturing Market Segmentation: By Formulation
3.7.1 Global HPAPI Contract Manufacturing Market, By Formulation Overview
3.7.2 Global HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global HPAPI Contract Manufacturing Market Segmentation: By End Use
3.8.1 Global HPAPI Contract Manufacturing Market, By End Use Overview
3.8.2 Global HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.4 Global HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.5 Global HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global HPAPI Contract Manufacturing Market, Regional Analysis
4.1 Regional Coverage of the Study
5. Americas HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)
5.1 Americas HPAPI Contract Manufacturing Market: Snapshot
5.2 Americas HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas HPAPI Contract Manufacturing Market: Key Factors
5.4 Americas HPAPI Contract Manufacturing Market Segmentation: By Formulation
5.4.1 Americas HPAPI Contract Manufacturing Market, By Formulation Overview
5.4.2 Americas HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.4 Americas HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.5 Americas HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas HPAPI Contract Manufacturing Market Segmentation: By End Use
5.5.1 Americas HPAPI Contract Manufacturing Market, By End Use Overview
5.5.2 Americas HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas HPAPI Contract Manufacturing Market Segmentation: By Country
5.6.1 United States HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.1.1 United States HPAPI Contract Manufacturing Market, By Formulation
5.6.1.2 United States HPAPI Contract Manufacturing Market, By End Use
5.6.2 Canada HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.2.1 Canada HPAPI Contract Manufacturing Market, By Formulation
5.6.2.2 Canada HPAPI Contract Manufacturing Market, By End Use
5.6.3 Rest of Americas HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.3.1 Rest of Americas HPAPI Contract Manufacturing Market, By Formulation
5.6.3.2 Rest of Americas HPAPI Contract Manufacturing Market, By End Use
6. Europe HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)
6.1 Europe HPAPI Contract Manufacturing Market: Snapshot
6.2 Europe HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe HPAPI Contract Manufacturing Market: Key Factors
6.4 Europe HPAPI Contract Manufacturing Market Segmentation: By Formulation
6.4.1 Europe HPAPI Contract Manufacturing Market, By Formulation Overview
6.4.2 Europe HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.4 Europe HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.5 Europe HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe HPAPI Contract Manufacturing Market Segmentation: By End Use
6.5.1 Europe HPAPI Contract Manufacturing Market, By End Use Overview
6.5.2 Europe HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe HPAPI Contract Manufacturing Market Segmentation: By Country
6.6.1 Germany HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.1.1 Germany HPAPI Contract Manufacturing Market, By Formulation
6.6.1.2 Germany HPAPI Contract Manufacturing Market, By End Use
6.6.2 Spain HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 Spain HPAPI Contract Manufacturing Market, By Formulation
6.6.2.2 Spain HPAPI Contract Manufacturing Market, By End Use
6.6.2 United Kingdom HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 United Kingdom HPAPI Contract Manufacturing Market, By Formulation
6.6.2.2 United Kingdom HPAPI Contract Manufacturing Market, By End Use
6.6.3 Switzerland HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.3.1 Switzerland HPAPI Contract Manufacturing Market, By Formulation
6.6.3.2 Switzerland HPAPI Contract Manufacturing Market, By End Use
6.6.4 Belgium HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.4.1 Belgium HPAPI Contract Manufacturing Market, By Formulation
6.6.4.2 Belgium HPAPI Contract Manufacturing Market, By End Use
6.6.5 Rest of Europe HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.5.1 Rest of Europe HPAPI Contract Manufacturing Market, By Formulation
6.6.5.2 Rest of Europe HPAPI Contract Manufacturing Market, By End Use
7. Asia-Pacific HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)
7.1 Asia-Pacific HPAPI Contract Manufacturing Market: Snapshot
7.2 Asia-Pacific HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific HPAPI Contract Manufacturing Market: Key Factors
7.4 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By Formulation
7.4.1 Asia-Pacific HPAPI Contract Manufacturing Market, By Formulation Overview
7.4.2 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.4 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.5 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By End Use
7.5.1 Asia-Pacific HPAPI Contract Manufacturing Market, By End Use Overview
7.5.2 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific HPAPI Contract Manufacturing Market Segmentation: By Country
7.6.1 China HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.1.1 China HPAPI Contract Manufacturing Market, By Formulation
7.6.1.2 China HPAPI Contract Manufacturing Market, By End Use
7.6.2 Japan HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.2.1 Japan HPAPI Contract Manufacturing Market, By Formulation
7.6.2.2 Japan HPAPI Contract Manufacturing Market, By End Use
7.6.3 India HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.3.1 India HPAPI Contract Manufacturing Market, By Formulation
7.6.3.2 India HPAPI Contract Manufacturing Market, By End Use
7.6.4 Rest of Asia-Pacific HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.4.1 Rest of Asia-Pacific HPAPI Contract Manufacturing Market, By Formulation
7.6.4.2 Rest of Asia-Pacific HPAPI Contract Manufacturing Market, By End Use
8. Middle-East & Africa HPAPI Contract Manufacturing Market: Historic and Forecast (2019-2029)
8.1 Middle-East & Africa HPAPI Contract Manufacturing Market: Snapshot
8.2 Middle-East & Africa HPAPI Contract Manufacturing Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa HPAPI Contract Manufacturing Market: Key Factors
8.4 Middle-East & Africa HPAPI Contract Manufacturing Market Segmentation: By Formulation
8.4.1 Middle-East & Africa HPAPI Contract Manufacturing Market, By Formulation Overview
8.4.2 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.4 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.5 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
8.5 Middle-East & Africa HPAPI Contract Manufacturing Market Segmentation: By End Use
8.5.1 Middle-East & Africa HPAPI Contract Manufacturing Market, By End Use Overview
8.5.2 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Global HPAPI Contract Manufacturing Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter’s Five Forces Analysis
10.1 Porter’s Five Forces Model
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of HPAPI Contract Manufacturing Market
11.4 Company Profiles
11.4.1 Lonza
11.4.2 Catalent, Inc.
11.4.3 Piramal Pharma Solutions
11.4.4 Pfizer CentreOne
11.4.5 Gentec Pharmaceutical Group
11.4.6 AbbVie Contract Manufacturing
11.4.7 Corden Pharma International
11.4.8 Curia Global, Inc.
11.4.9 Merck Group (SigmaAldrich Co., LLC)
11.4.10 Polpharma Group
List of Figures
Figure 1: Age-standardised cancer incidence rate, 2020*
Figure 2: Estimated number of prevalent cases (5-year) World
Figure 3: Global HPAPI Contract Manufacturing Market Size, By Value, 2019-2022 (USD Billion)
Figure 4: Global HPAPI Contract Manufacturing Market Size, By Value, 2023-2029 (USD Billion)
Figure 5: Global HPAPI Contract Manufacturing Market Share, By Formulation, 2022 (%)
Figure 6: Global HPAPI Contract Manufacturing Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 7: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Injectables, 2019-2029 (USD Billion)
Figure 8: Global HPAPI Contract Manufacturing Market Size, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 9: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Oral Solids, 2019-2029 (USD Billion)
Figure 10: Global HPAPI Contract Manufacturing Market Size, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 11: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Lotions, 2019-2029 (USD Billion)
Figure 12: Global HPAPI Contract Manufacturing Market Size, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 13: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Other Formulations, 2019-2029 (USD Billion)
Figure 14: Global HPAPI Contract Manufacturing Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 15: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Oncology, 2019-2029 (USD Billion)
Figure 16: Global HPAPI Contract Manufacturing Market Size, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 17: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Antidiabetics, 2019-2029 (USD Billion)
Figure 18: Global HPAPI Contract Manufacturing Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 19: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Autoimmune, 2019-2029 (USD Billion)
Figure 20: Global HPAPI Contract Manufacturing Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 21: Global HPAPI Contract Manufacturing Market Absolute Opportunity, By Others, 2019-2029 (USD Billion)
Figure 22: Americas HPAPI Contract Manufacturing Market Size, By Value, 2019H-2029F (USD Billion)
Figure 23: Americas HPAPI Contract Manufacturing Market Share, By Formulation, 2022 (%)
Figure 24: Americas HPAPI Contract Manufacturing Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas HPAPI Contract Manufacturing Market, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas HPAPI Contract Manufacturing Market, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Americas HPAPI Contract Manufacturing Market, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 28: Americas HPAPI Contract Manufacturing Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 29: Americas HPAPI Contract Manufacturing Market, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 30: Americas HPAPI Contract Manufacturing Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: Americas HPAPI Contract Manufacturing Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 32: United States HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 33: United States HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 34: United States HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 35: United States HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 36: Canada HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 37: Canada HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 38: Canada HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 39: Canada HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 40: Rest of Americas HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 41: Rest of Americas HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 42: Rest of Americas HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 43: Rest of Americas HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 44: Europe HPAPI Contract Manufacturing Market Size, By Value, 2019H-2029F (USD Billion)
Figure 45: Europe HPAPI Contract Manufacturing Market Share, By Formulation, 2022 (%)
Figure 46: Europe HPAPI Contract Manufacturing Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe HPAPI Contract Manufacturing Market, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe HPAPI Contract Manufacturing Market, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe HPAPI Contract Manufacturing Market, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Europe HPAPI Contract Manufacturing Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 51: Europe HPAPI Contract Manufacturing Market, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 52: Europe HPAPI Contract Manufacturing Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 53: Europe HPAPI Contract Manufacturing Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 54: Germany HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 55: Germany HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 56: Germany HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 57: Germany HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 58: Spain HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 59: Spain HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 60: Spain HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 61: Spain HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 62: United Kingdom HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 63: United Kingdom HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 64: United Kingdom HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 65: United Kingdom HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 66: Switzerland HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 67: Switzerland HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 68: Switzerland HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 69: Switzerland HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 70: Belgium HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 71: Belgium HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 72: Belgium HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 73: Belgium HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 74: Rest of Europe HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 75: Rest of Europe HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 76: Rest of Europe HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 77: Rest of Europe HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 78: Asia Pacific HPAPI Contract Manufacturing Market Size, By Value, 2019H-2029F (USD Billion)
Figure 79: Asia Pacific HPAPI Contract Manufacturing Market Share, By Formulation, 2022 (%)
Figure 80: Asia Pacific HPAPI Contract Manufacturing Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 81: Asia Pacific HPAPI Contract Manufacturing Market, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 82: Asia Pacific HPAPI Contract Manufacturing Market, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 83: Asia Pacific HPAPI Contract Manufacturing Market, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 84: Asia Pacific HPAPI Contract Manufacturing Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 85: Asia Pacific HPAPI Contract Manufacturing Market, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 86: Asia Pacific HPAPI Contract Manufacturing Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 87: Asia Pacific HPAPI Contract Manufacturing Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 88: China HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 89: China HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 90: China HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 91: China HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 92: Japan HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 93: Japan HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 94: Japan HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 95: Japan HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 96: India HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 97: India HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 98: India HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 99: India HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 100: Rest of Asia Pacific HPAPI Contract Manufacturing Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 101: Rest of Asia Pacific HPAPI Contract Manufacturing Market Value, By Formulation, 2022 (USD Billion)
Figure 102: Rest of Asia Pacific HPAPI Contract Manufacturing Market Share, By Formulation, By Value, 2022 (%)
Figure 103: Rest of Asia Pacific HPAPI Contract Manufacturing Market Share, By End Use, 2022 (%)
Figure 104: Middle East and Africa HPAPI Contract Manufacturing Market Size, By Value, 2019H-2029F (USD Billion)
Figure 105: Middle East and Africa HPAPI Contract Manufacturing Market Share, By Formulation, 2022 (%)
Figure 106: Middle East and Africa HPAPI Contract Manufacturing Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 107: Middle East and Africa HPAPI Contract Manufacturing Market, By Oral Solids, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 108: Middle East and Africa HPAPI Contract Manufacturing Market, By Lotions, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 109: Middle East and Africa HPAPI Contract Manufacturing Market, By Other Formulations, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 110: Middle East and Africa HPAPI Contract Manufacturing Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Middle East and Africa HPAPI Contract Manufacturing Market, By Antidiabetics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Middle East and Africa HPAPI Contract Manufacturing Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Middle East and Africa HPAPI Contract Manufacturing Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: Global Impact of Drivers and Restraints
Figure 115: Market Share of Prominent Companies of HPAPI Contract Manufacturing Market, 2022 (%)
Figure 116: Lonza Revenues, 2020-2022 (USD Million)
Figure 117: Lonza Revenue, By Business Segments, 2022 (%)
Figure 118: Catalent, Inc. Revenues, 2020-2022 (USD Million)
Figure 119: Catalent, Inc, By Geographic segment, 2022 (%)
Figure 120: Catalent, Inc, By Business Segments, 2022 (%)
Figure 121: Piramal Pharma Solutions Revenues, 2020-2022 (USD Million)
Figure 122: Piramal Pharma Solutions Revenue, By Geographic Segment, 2022 (%)
Figure 123: Piramal Pharma Solutions Revenue, By Business Segments, 2022 (%)
Figure 124: Pfizer Revenues, 2020-2022 (USD Million)
Figure 125: Pfizer Revenues, By Business Segments, 2022 (%)
Figure 126: Pfizer Inc. Revenue, By Geographical Segments, 2022 (%)
Figure 127: Merck Group Revenues, 2020-2022 (USD Million)
Figure 128: Merck Group Revenues, By Geographic Segments, 2022 (%)
Figure 129: Merck Group Revenue, By Business Segments, 2022 (%)
List of Tables
Table A1: Competitive landscape for Highly Potent drugs in Pipeline
Table A2: United States HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A3: United States HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A4: United States HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A5: United States HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A6: Canada HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A7: Canada HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A8: Canada HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A9: Canada HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A10: Rest of Americas HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A11: Rest of Americas HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A12: Rest of Americas HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A13: Rest of Americas HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A14: Germany HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A15: Germany HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A16: Germany HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A17: Germany HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A18: Spain HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A19: Spain HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A20: Spain HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A21: Spain HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A22: United Kingdom HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A23: United Kingdom HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A24: United Kingdom HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A25: United Kingdom HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A26: Switzerland HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A27: Switzerland HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A28: Switzerland HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A29: Switzerland HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A30: Belgium HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A31: Belgium HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A32: Belgium HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A33: Belgium HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A34: Rest of Europe HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A35: Rest of Europe HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A36: Rest of Europe HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A37: Rest of Europe HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A38: China HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A39: China HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A40: China HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A41: China HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A42: Japan HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A43: Japan HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A44: Japan HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A45: Japan HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A46: India HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A47: India HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A48: India HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A49: India HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A50: Rest of Asia Pacific HPAPI Contract Manufacturing Market, By Formulation, By Value, 2019-2022 (USD Billion)
Table A51: Rest of Asia Pacific HPAPI Contract Manufacturing Market, By Formulation, By Value, 2023-2029 (USD Billion)
Table A52: Rest of Asia Pacific HPAPI Contract Manufacturing Market, By End Use, By Value, 2019-2022 (USD Billion)
Table A53: Rest of Asia Pacific HPAPI Contract Manufacturing Market, By End Use, By Value, 2023-2029 (USD Billion)
Table A54: Lonza Key Financials, 2020-2022
Table A55: Catalent, Inc. Key Financials, 2020-2022
Table A56: Piramal Pharma Solutions Key Financials, 2020-2022
Table A57: Pfizer Key Financials, 2020-2022
Table A58: Merck Group. Key Financials, 2020-2022
Global Pneumatic Tourniquet Market (2024 Edition): Analysis By Type (Single-Blad ...
Read MoreGlobal Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Ty ...
Read MoreGlobal General Medical and Surgical Hospitals Market (2024 Edition): Analysis By ...
Read MoreGlobal Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Art ...
Read MoreGlobal Buccal Drug Delivery Systems (2024 Edition): Analysis By Product (Subling ...
Read MoreGlobal Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatme ...
Read MoreGlobal Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indica ...
Read MoreGlobal Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extra ...
Read MoreNo matter the hour, we’re here to help.
Contact us now!Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research solutions and consulting services.
© 2024 Azoth Analytics | All rights reserved